Charite University
Berlin, 14169, Germany
NCT Number: NCT04653727
The outbreak of the novel coronavirus SARS-CoV-2 caused a health emergency of international proportions when it was declared by the World Health Organization (WHO) in January 2020. Since then, the virus has spread internationally and the WHO has classified the outbreak as a pandemic. In the context of the increasing reporting of this pandemic and the increasing governmental measures to limit or slow down the spread of SARS-CoV-2 by all means, there is so far little scientific evidence for the effects of a healthy lifestyle on the disease. The aim of this study is to compare the potential of different, possibly protective lifestyles using the example of the COVID-19 pandemic. We will conduct an online survey with 3.000 participants using mobile website technology.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Berlin, 14169, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention.
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed when filling out the questionnaire (Baseline)
The scale ranges from 0 to 100, where 0 is the lowest level of well-being / lowest quality of life and 100 is the highest level of well-being / highest quality of life.
Time frame: Assessed retrospectively (last 6 months) with self-designed question
The NAS ranges from 0 to 10, where 0 is the lowest level of stress and 10 is the highest level of stress.
Time frame: Assessed retrospectively (last 6 months) with self-designed question
The NAS ranges from 0 to 10, where 0 is the lowest level of anxiety and 10 is the highest level of anxiety.
Time frame: Assessed retrospectively (last 6 months) with self-designed question
The NAS ranges from 0 to 10, where 0 is the lowest level of anxiety and 10 is the highest level of anxiety.
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Assessed when filling out the questionnaire (Baseline)
The scale ranges from 0 to 100, where 0 is the lowest level of self-efficacy and 100 is the highest level of self-efficacy.
Time frame: Assessed retrospectively (last 6 months) with self-designed question
Time frame: Conducted 1 month after completion of the questionnaire (once)
Charite University, Berlin, Germany
Other
Effects of Interventions and Lifestyle Modifications in Integrative Medicine and the Course of Infectious Respiratory Diseases Including COVID-19
Acronym: AtemNHK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04606407
COVID-19, Coronaviridae Infections
Jerusalem, Israel
View Trial DetailsNCT04860206
COVID-19, Cognition Disorders
Izola, Slovenia
View Trial DetailsNCT04649736
Behavior, COVID-19
Lima, Peru
View Trial DetailsNCT04581096
Behavior, COVID-19
Valencia, Spain
View Trial Details